Maximus (NYSE:MMS) Stock Rating Lowered by StockNews.com

Maximus (NYSE:MMS - Get Free Report) was downgraded by stock analysts at StockNews.com from a "buy" rating to a "hold" rating in a report issued on Thursday.

Maximus Price Performance

Shares of NYSE MMS opened at $75.02 on Thursday. The stock has a market cap of $4.25 billion, a price-to-earnings ratio of 16.13 and a beta of 0.61. The company has a debt-to-equity ratio of 0.82, a quick ratio of 1.72 and a current ratio of 1.72. Maximus has a fifty-two week low of $63.77 and a fifty-two week high of $93.97. The firm's 50-day simple moving average is $68.47 and its 200 day simple moving average is $72.92.

Maximus (NYSE:MMS - Get Free Report) last issued its quarterly earnings data on Thursday, May 8th. The health services provider reported $2.01 EPS for the quarter, topping the consensus estimate of $1.37 by $0.64. The firm had revenue of $1.36 billion during the quarter, compared to the consensus estimate of $1.29 billion. Maximus had a return on equity of 21.95% and a net margin of 5.28%. The company's quarterly revenue was up 1.0% compared to the same quarter last year. During the same period in the prior year, the business posted $1.57 earnings per share. As a group, research analysts anticipate that Maximus will post 6.15 earnings per share for the current fiscal year.

Insider Buying and Selling at Maximus

In other news, Director Jan Madsen sold 2,439 shares of the stock in a transaction on Tuesday, March 18th. The stock was sold at an average price of $67.71, for a total transaction of $165,144.69. Following the completion of the transaction, the director now owns 18,097 shares in the company, valued at approximately $1,225,347.87. This represents a 11.88% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, insider Ilene R. Baylinson sold 14,500 shares of Maximus stock in a transaction dated Wednesday, February 19th. The stock was sold at an average price of $68.14, for a total value of $988,030.00. Following the completion of the sale, the insider now directly owns 2,512 shares of the company's stock, valued at approximately $171,167.68. This trade represents a 85.23% decrease in their position. The disclosure for this sale can be found here. Corporate insiders own 1.60% of the company's stock.

Institutional Trading of Maximus

Institutional investors have recently modified their holdings of the business. Comerica Bank grew its stake in Maximus by 6.4% in the 1st quarter. Comerica Bank now owns 28,640 shares of the health services provider's stock valued at $1,953,000 after buying an additional 1,721 shares in the last quarter. Walleye Capital LLC boosted its holdings in shares of Maximus by 162.3% in the first quarter. Walleye Capital LLC now owns 134,743 shares of the health services provider's stock worth $9,188,000 after acquiring an additional 83,373 shares during the period. Hotchkis & Wiley Capital Management LLC grew its position in shares of Maximus by 17.5% in the first quarter. Hotchkis & Wiley Capital Management LLC now owns 188,865 shares of the health services provider's stock valued at $12,879,000 after purchasing an additional 28,075 shares in the last quarter. AlphaQuest LLC raised its stake in shares of Maximus by 73.8% during the 1st quarter. AlphaQuest LLC now owns 3,580 shares of the health services provider's stock valued at $244,000 after purchasing an additional 1,520 shares during the period. Finally, Martingale Asset Management L P lifted its holdings in Maximus by 7.5% during the 1st quarter. Martingale Asset Management L P now owns 35,900 shares of the health services provider's stock worth $2,448,000 after purchasing an additional 2,516 shares in the last quarter. 97.21% of the stock is currently owned by hedge funds and other institutional investors.

Maximus Company Profile

Maximus, Inc operates as a provider of government services in the United States and internationally. It operates through three segments: U.S. Federal Services, U.S. Services, and Outside the U.S. The U.S. Services segment offers program eligibility support and enrollment; centralized multilingual customer contact centers, multichannel, and digital self-service options for enrollment; application assistance and independent health plan choice counseling; beneficiary outreach, education, eligibility, enrollment, and redeterminations; and person-centered independent disability, long-term sick, and other health assessments.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.